Wix.com (WIX) PT Lowered to $70 at Oppenheimer; Reiterates Outperform

Oppenheimer lowered its price target on Wix.com (NASDAQ: WIX) to $70.00 (from $88.00) while maintaining a Outperform rating following the company's 3Q earnings report. While WIX exceeded Street Collections by 2%, EBITDA missed by 36% on higher R&D and G&A on organic spending and currency.

FY '17E R&D includes $8.5M for Deviantart, with similar levels expected in '18E. Since WIX's R&D staff is based in Israeli, stronger NIS expected to increases '18E R&D by $12M.

You May Also Be Interested In

• Incyte (INCY) PT Raised to $105 at Truist Securities
• Eledon Pharamceuticals (ELDN) PT Raised to $7 at Leerink
• UnitedHealth Group (UNH) PT Lowered to $197 at TD Cowen